These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30187173)

  • 1. Melanocortin 2 receptor antagonists in canine pituitary-dependent hypercortisolism: in vitro studies.
    Sanders K; Mol JA; Kooistra HS; Galac S
    Vet Res Commun; 2018 Dec; 42(4):283-288. PubMed ID: 30187173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroidogenic factor-1 inverse agonists as a treatment option for canine hypercortisolism: in vitro study.
    Sanders K; Mol JA; Slob A; Kooistra HS; Galac S
    Domest Anim Endocrinol; 2018 Apr; 63():23-30. PubMed ID: 29223003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of potent selective competitive-antagonists of the melanocortin type 2 receptor.
    Bouw E; Huisman M; Neggers SJ; Themmen AP; van der Lely AJ; Delhanty PJ
    Mol Cell Endocrinol; 2014 Aug; 394(1-2):99-104. PubMed ID: 25017734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanocortin 2 receptor-associated protein (MRAP) and MRAP2 in human adrenocortical tissues: regulation of expression and association with ACTH responsiveness.
    Hofland J; Delhanty PJ; Steenbergen J; Hofland LJ; van Koetsveld PM; van Nederveen FH; de Herder WW; Feelders RA; de Jong FH
    J Clin Endocrinol Metab; 2012 May; 97(5):E747-54. PubMed ID: 22419722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRH-induced secretion of adrenocorticotropin and cortisol in dogs with pituitary-dependent hypercortisolism.
    Pijnacker T; Knies M; Galac S; Sanders K; Mol JA; Kooistra HS
    Vet Q; 2018 Dec; 38(1):72-78. PubMed ID: 30362899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activating mutations of GNAS in canine cortisol-secreting adrenocortical tumors.
    Kool MM; Galac S; Spandauw CG; Kooistra HS; Mol JA
    J Vet Intern Med; 2013; 27(6):1486-92. PubMed ID: 24112376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen Suppresses Interaction of Melanocortin 2 Receptor and Its Accessory Protein in the Primate Fetal Adrenal Cortex.
    Babischkin JS; Aberdeen GW; Pepe GJ; Albrecht ED
    Endocrinology; 2016 Dec; 157(12):4588-4601. PubMed ID: 27779913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin inhibits the activation of melanocortin receptors 2 and 3 in vitro: A possible mechanism for its anti-androgenic and weight balancing effects in vivo?
    Parween S; Rihs S; Flück CE
    J Steroid Biochem Mol Biol; 2020 Jun; 200():105684. PubMed ID: 32360359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside Rd attenuates ACTH-induced corticosterone secretion by blocking the MC2R-cAMP/PKA/CREB pathway in Y1 mouse adrenocortical cells.
    Jin W; Ma R; Zhai L; Xu X; Lou T; Huang Q; Wang J; Zhao D; Li X; Sun L
    Life Sci; 2020 Mar; 245():117337. PubMed ID: 31972205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of selegiline and trilostane combined therapy efficacy for canine pituitary-dependent hypercortisolism treatment: A pilot randomized clinical trial.
    de Carvalho GLC; Meirelles L; da Silva CC; Neto WS; Furtado PV; Machado L; de Moura Martins FS; da Silva Mello FP; de Faria Valle S; Pöppl ÁG
    Res Vet Sci; 2022 Dec; 150():107-114. PubMed ID: 35809414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of trilostane on the pituitary-adrenocortical and renin-aldosterone axis in dogs with pituitary-dependent hypercortisolism.
    Galac S; Buijtels JJCWM; Mol JA; Kooistra HS
    Vet J; 2010 Jan; 183(1):75-80. PubMed ID: 19042143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localisation of the melanocortin-2-receptor and its accessory proteins in the developing and adult adrenal gland.
    Gorrigan RJ; Guasti L; King P; Clark AJ; Chan LF
    J Mol Endocrinol; 2011 Jun; 46(3):227-32. PubMed ID: 21367968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The melanocortin 2 receptor accessory protein exists as a homodimer and is essential for the function of the melanocortin 2 receptor in the mouse y1 cell line.
    Cooray SN; Almiro Do Vale I; Leung KY; Webb TR; Chapple JP; Egertová M; Cheetham ME; Elphick MR; Clark AJ
    Endocrinology; 2008 Apr; 149(4):1935-41. PubMed ID: 18162519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the ACTH receptor, steroidogenic acute regulatory protein, and steroidogenic enzymes in canine cortisol-secreting adrenocortical tumors.
    Galac S; Kool MM; Naan EC; Daminet S; Mol JA; Kooistra HS
    Domest Anim Endocrinol; 2010 Nov; 39(4):259-67. PubMed ID: 20920783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of baseline cortisol concentration to monitor efficacy of twice-daily administration of trilostane to dogs with pituitary-dependent hyperadrenocorticism: 22 cases (2008-2012).
    Woolcock AD; Bugbee AC; Creevy KE
    J Am Vet Med Assoc; 2016 Apr; 248(7):814-21. PubMed ID: 27003023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bursal anti-steroidogenic peptide (BASP) on cortisol biosynthesis in ACTH-stimulated canine adrenocortical carcinoma cells in vitro.
    Byrd JA; Dean CE; Fossum TW; Hargis BM
    Vet Immunol Immunopathol; 1995 Jul; 47(1-2):35-42. PubMed ID: 8533298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a melanocortin type 2 receptor (MC2R) antagonist on the corticosterone response to hypoxia and ACTH stimulation in the neonatal rat.
    Goldenberg AJ; Gehrand AL; Waples E; Jablonski M; Hoeynck B; Raff H
    Am J Physiol Regul Integr Comp Physiol; 2018 Jul; 315(1):R128-R133. PubMed ID: 29718699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization, tissue-specific expression, and regulation of melanocortin 2 receptor in rainbow trout.
    Aluru N; Vijayan MM
    Endocrinology; 2008 Sep; 149(9):4577-88. PubMed ID: 18535097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbenoxolone Disodium Treatment for Canine Pituitary-Dependent Hyperadrenocorticism.
    Teshima T; Matsumoto H; Okusa T; Uchiyama R; Koyama H
    PLoS One; 2016; 11(11):e0166267. PubMed ID: 27824928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid as a novel medical therapy for Cushing's disease in dogs.
    Castillo V; Giacomini D; Páez-Pereda M; Stalla J; Labeur M; Theodoropoulou M; Holsboer F; Grossman AB; Stalla GK; Arzt E
    Endocrinology; 2006 Sep; 147(9):4438-44. PubMed ID: 16740975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.